Radretumab
Based on 1 Customer Validation
Radretumab is a human antibody used for imaging and radioimmunotherapy. Radretumab binds with high affinity to the oncofetal ED-B fibronectin isoform in tumor blood vessels and the extracellular matrix, preferentially localizing to tumor blood vessels without affecting normal tissues. Radretumab can be used in research on brain metastases of solid cancers, teratocarcinoma, and relapsed hematologic malignancies.
For research use only. We do not sell to patients.
- Purity : 98.56%
- CAS No.: 1253180-81-2
- Molecular Weight:144.20 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 1253180-81-2
-
Appearance Liquid
-
Molecular Weight 144.20 kDa
-
Color Colorless to light yellow
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (258 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)